Write For Us

The Threat of Tainted Cancer Drugs

Sponsored Post Vitamin D2 Canada Persia
56 Views
Published
In 2019, doctors at hospitals in Colombia began reporting that patients treated with a commonly used cancer drug were developing high fevers, “altered states of consciousness” and other concerning symptoms.

They suspected that more than 100 patients had suffered reactions linked to the contaminated medicine. Four children died, including a six-year-old girl named Valery.

The drug they were given was made by Naprod Life Sciences in India, a crucial but sometimes unnoticed maker of low-cost generic cancer medicine. None of the medicine the company makes is approved for sale in the US, where regulations are tougher. Naprod can sell some medicine in Europe but said it currently is not.

This is the story of how a drugmaker with a record of safety lapses and quality concerns keeps selling medicine, leaving patients and families to suffer the consequences.
--------
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: http://www.youtube.com/bloomberg/join

Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.

Subscribe for business news, but not as you've known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.

Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
Category
Business
Tags
News, bloomberg, quicktake
Sign in or sign up to post comments.
Be the first to comment